Inimmune
  • About
    • Vision/Mission
    • About Us
    • Management Team
    • Board of Directors
  • Pipeline
  • Research
  • News
  • Investors
  • Careers
  • Contact
Select Page
For Missoula’s Inimmune, a $22 M Series A Round with Two Bear Capital is the latest record set – MT High Tech Business Alliance

For Missoula’s Inimmune, a $22 M Series A Round with Two Bear Capital is the latest record set – MT High Tech Business Alliance

Feb 15, 2021 | News

https://www.mthightech.org/news/inimmune-biotech-case-study
Nation angler Evans helping with vital COVID research

Nation angler Evans helping with vital COVID research

Feb 15, 2021 | News

<https://www.bassmaster.com/news/nation-angler-evans-helping-vital-covid-research?j=23264113&sfmc_sub=1646391083&l=4168516_HTML&u=507970617&mid=10688361&jb=0>
UM Receives Largest Single Research Award in its History

UM Receives Largest Single Research Award in its History

Oct 2, 2020 | News

Inimmune is a collaborator in the University of Montana’s effort to bring opioid vaccines to clinical trials.
Inimmune raises $22 Million in Series A Funding Led by Two Bear Capital

Inimmune raises $22 Million in Series A Funding Led by Two Bear Capital

Jul 9, 2020 | News

(Missoula, MT) Inimmune, www.inimmune.com, a biotechnology company developing immune therapies and components for more effective vaccines, announced today that it raised $22 million in Series A funding. It was the Missoula-based company’s first outside...

Biotech Company Announces $22 Million Investment Led by Mike Goguen’s Firm

Jul 9, 2020 | News

Inimmune lands the an $22 million dollar investment, let by Two Bear Capital. The investment is believed to be largest Series A funding in state history; Inimmune, which is based in Missoula, Montana, specializes in adjuvants for vaccines and has been developing a...

Montana Biotech Company Receives $2 M Small Business Innovation Research Grant to Advance Vaccine Technologies

Jul 1, 2020 | News

Inimmune Corporation, a biotechnology company located in Missoula, MT, was recently awarded a $2 M grant from the National Institute for Allergy and Infectious Diseases (NIAID) under its Small Business Innovation Research (SBIR) Direct to Phase II program to advance a...
« Older Entries

Recent Posts

  • For Missoula’s Inimmune, a $22 M Series A Round with Two Bear Capital is the latest record set – MT High Tech Business Alliance
  • Nation angler Evans helping with vital COVID research
  • UM Receives Largest Single Research Award in its History
  • Inimmune raises $22 Million in Series A Funding Led by Two Bear Capital
  • Biotech Company Announces $22 Million Investment Led by Mike Goguen’s Firm

Archives

  • February 2021
  • October 2020
  • July 2020
  • June 2020
  • October 2019
  • December 2018
  • February 2018
  • July 2017
  • November 2016
  • August 2016

BACK TO NEWS

© 2020 Inimmune